Amneal to Report Third Quarter 2025 Results on October 30, 2025

Core Viewpoint - Amneal Pharmaceuticals, Inc. is set to release its third quarter 2025 financial results on October 30, 2025, prior to market opening, and will host an audio webcast for investors [1][2]. Company Overview - Amneal Pharmaceuticals, Inc. is a global biopharmaceutical company headquartered in Bridgewater, NJ, with a diverse portfolio of over 280 pharmaceuticals primarily in the United States [3]. - The company operates in multiple segments, including Affordable Medicines, which focuses on complex product categories and therapeutic areas such as injectables and biosimilars, and Specialty, which emphasizes branded pharmaceuticals for central nervous system and endocrine disorders [3]. - Through its AvKARE segment, Amneal distributes pharmaceuticals and other products for the U.S. federal government, retail, and institutional markets [3].